Arvee Laboratories (India) bulk deals, insider trading and stake changes
NSE: ARVEEChemicals & PetrochemicalsSmall Cap
Last close ₹189.07down ₹8.31 (4.21%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹197.38.
52-week range of traded prices to 23 Oct 2026
₹129.11Low, 30 Mar 2026₹290.78High, 19 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹208 Cr2,476th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 51.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 6.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,57751.7% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Arvee Laboratories (India) promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Others0 purchases, 2 salesNo purchase₹0.09 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹0.09 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Arvee Laboratories (India) insider trading
All 11 disclosures on record.Insider trading, all companies
Sep 2026
- Saurin Ajitbhai Gandhi₹0.07 Cr3,010 sharesSold · KMP · 24 Sep 2026 · disclosed 25 Sep · held 3,010 before, holds none after
- Saurin Ajitbhai Gandhi₹0.02 Cr990 sharesSold · KMP · 23 Sep 2026 · disclosed 25 Sep · stake 0.04% before, 0.03% after
Dec 2022
- MITABEN BHARATBHAI CHOKSHI6,69,000sharesReceived · Promoter Group · 27 Dec 2022 · Inter-se-Transfer · stake 18.50% before, 24.57% after
- SAUMIL BHARATBHAI CHOKSHI6,69,000sharesGave · Promoter Group · 27 Dec 2022 · Inter-se-Transfer · held 6,69,000 before
Sep 2022
- MITABEN BHARAT CHOKSHI20,39,000sharesReceived · Promoter Group · 14 Sep 2022 · Gift · holds 20,39,000 after, stake 18.50% after
- BHARAT RASIKLAL CHOKSHI13,70,000sharesGave · Promoter Group · 14 Sep 2022 · Gift · held 13,70,000 before
- SHALIN BHARATBHAI CHOKSHI13,37,000sharesGave · Promoters · 14 Sep 2022 · Off Market · stake 12.14% before, 0.01% after
- Saumil Bharat Chokshi6,69,000sharesGave · Promoter Group · 14 Sep 2022 · Gift · stake 12.14% before, 6.07% after
- KAVITA SHALIN CHOKSHI13,37,000sharesReceived · Promoter Group · 14 Sep 2022 · Gift · stake 0.02% before, 12.15% after
Feb 2022
- SUDHAKARBHAI CHHOTABHAI PATEL₹6.04 Cr6,62,000 sharesSold or invoked · Promoter · 3 Feb 2022 · disclosed 16 Mar
- SHALIN SUDHAKARBHAI PATEL6,62,000sharesReceived · Promoters · 3 Feb 2022 · disclosed 9 Feb · Others · stake 30.67% before, 36.67% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Arvee Laboratories (India) stake sales and purchases
All 2 disclosures on record.
Dec 2022
- SoldSAUMIL BHARAT CHOKSHI · promoter6.07% of the company6,69,000 sharesholds none after27 Dec 2022 · filed under the 2% rule · Inter-se transfer
Sep 2022
- SoldBHARAT RASIKLAL CHOKSHI · promoter12.43% of the company13,70,000 sharesholds none after14 Sep 2022 · filed under the 2% rule · Inter-se transfer
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Arvee Laboratories (India) bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
BonusEach share became 2 on 13 Oct 2020. The lines below are on the share count before it.
Thursday 8 Mar 20182 firms · ₹0.14 Cr bought · ₹0.34 Cr soldNet sold ₹0.20 Cr
- SoldSHAH MISHA ASHISHSold 32,000 at ₹50.46₹0.16 Cr
- Both waysPRAMOD VASWANI HUFBought 28,000 at ₹49.10Sold 28,000 at ₹62.98Net nil₹0.14 Cr bought
Monday 5 Mar 20182 firms · ₹0.19 Cr bought · ₹0.25 Cr soldNet sold ₹0.06 Cr
- SoldHUF SHAH ASHISH NAVNITLALSold 44,000 at ₹57.83₹0.25 Cr
- BoughtSHAH MISHA ASHISHBought 32,000 at ₹59.63₹0.19 Cr
Wednesday 28 Feb 20182 firms · ₹0.54 Cr bought · ₹0.51 Cr soldNet bought ₹0.03 Cr
- BoughtPATEL GITABEN DINEHSBHAIBought 96,000 at ₹56.14₹0.54 Cr
- SoldHUF SHAH ASHISH NAVNITLALSold 90,000 at ₹56.15₹0.51 Cr
Tuesday 27 Feb 20183 firms · ₹1.52 Cr bought · ₹1.40 Cr soldNet bought ₹0.12 Cr
- SoldHUF SHAH ASHISH NAVNITLALSold 2,32,000 at ₹60.17₹1.40 Cr
- BoughtPATEL GITABEN DINEHSBHAIBought 1,60,000 at ₹60.13₹0.96 Cr
- BoughtPATEL PRANAVBought 92,000 at ₹60.16₹0.55 Cr
Monday 26 Feb 20183 firms · ₹0.73 Cr bought · ₹0.63 Cr soldNet bought ₹0.10 Cr
- SoldHUF SHAH ASHISH NAVNITLALSold 1,04,000 at ₹60.70₹0.63 Cr
- BoughtPATEL MADHUBEN JASHBHAIBought 80,000 at ₹60.81₹0.49 Cr
- BoughtPATEL GITABEN DINEHSBHAIBought 40,000 at ₹60.56₹0.24 Cr
Thursday 22 Feb 20183 firms · ₹4.11 Cr bought · ₹0 soldNet bought ₹4.11 Cr
- BoughtHUF SHAH ASHISH NAVNITLALBought 4,70,000 at ₹63.23₹2.97 Cr
- BoughtPATEL JASHBHAIBought 1,36,000 at ₹63.36₹0.86 Cr
- BoughtPATEL MADHUBEN JASHBHAIBought 44,000 at ₹62.24₹0.27 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 16 deals on record since listing on 22 Feb 2018.